Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TGM2 | P21980 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7638735 | 1.00 | LMNA (0.57) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7638567 | 0.94 | LMNA (0.50) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7642929 | 0.94 | LMNA (0.50) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7638559 | 0.94 | LMNA (0.50) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7640456 | 0.90 | LMNA (0.47) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7637266 | 0.90 | LMNA (0.45) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7637275 | 0.90 | LMNA (0.45) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL312263 | 0.89 | LMNA (0.44) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL7641168 | 0.89 | LMNA (0.44) | LMNAKMT2APOLBALDH1A1TGM2 | |
| SCHEMBL313679 | 0.89 | LMNA (0.44) | LMNAKMT2APOLBALDH1A1TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6462183-B1 | SOLID PHASE OLIGOSACCHARIDE SYNTHESIS | ALCHEMIA PTY LTD (AU) | 2002-10-08 | — | — | US | claimed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-6462183-B1 | SOLID PHASE OLIGOSACCHARIDE SYNTHESIS | ALCHEMIA PTY LTD (AU) | 2002-10-08 | — | — | US | disclosed |
| EP-0977763-A4 | PROTECTED AMINOSUGARS | ALCHEMIA PTY LTD (AU) | 2000-07-12 | — | — | EP | disclosed |
| EP-0977763-A1 | PROTECTED AMINOSUGARS | Alchemia Pty. Ltd. (AU) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998038197-A1 | PROTECTED AMINOSUGARS | ALCHEMIA PTY. LTD. (AU) | 1998-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | SLC5A1, UGGT1, MRPL21 | LMNA 4069/4885KMT2A 3620/4885POLB 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.